Gene expression profiling of human hepatoblastoma using archived formalin-fixed and paraffin-embedded tissues
- 3 March 2011
- journal article
- research article
- Published by Springer Nature in Virchows Archiv
- Vol. 458 (4), 453-465
- https://doi.org/10.1007/s00428-011-1043-8
Abstract
We elucidated the genetic profile of hepatoblastomas (HBLs) to identify diagnostic and prognostic markers. RNA was extracted from 32 formalin-fixed, paraffin-embedded HBLs and corresponding nonneoplastic liver (NNL) tissues, and cDNA-mediated annealing, selection, extension, and ligation (DASL) chip assays were performed. Immunohistochemistry was performed to confirm the expression of Yin Yang 1 (YY1) protein in HBL. Twenty-four genes that were associated with signal transduction, cell–cell adhesion, cell cycle regulation, and apoptosis were differentially expressed in HBL and NNL tissues. Two apoptosis-associated genes, MYCN and BIRC5, were highly upregulated in HBL. Eight genes, including YY1 and IGF1, were upregulated in HBL cases that had a poor prognosis. Thirty-eight genes, including YY1, were differentially expressed according to histologic differentiation of HBL, and the immunohistochemical expression of YY1 was correlated with poor HBL differentiation. Thus, using DASL chip assays, we report the gene expression profiles of HBL, which suggest new candidate prognostic and diagnostic genetic markers and putative therapeutic targets for HBL.Keywords
This publication has 32 references indexed in Scilit:
- Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathwaysHuman Pathology, 2009
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patientsAnnals of Oncology, 2008
- Hepatoblastoma in a Noonan syndrome patient with a PTPN11 mutationPediatric Blood & Cancer, 2008
- Sporadic childhood hepatoblastomas show activation of β-catenin, mismatch repair defects and p53 mutationsLaboratory Investigation, 2008
- Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas†Hepatology, 2006
- Pharmacogenomic Identification of Novel Determinants of Response to Chemotherapy in Colon CancerCancer Research, 2006
- MYCN in neuronal tumoursCancer Letters, 2003
- Where do we stand with hepatoblastoma?Cancer, 2003
- Delineation of prognostic biomarkers in prostate cancerNature, 2001